Target intelligence / Profile preview

Human 80S ribosome (80S ribosome)

Target
80S ribosome
Molecular classification
Enzyme, Ribonucleoprotein complex, Translation machinery
01

Overview

The human 80S ribosome is the primary site of protein synthesis in eukaryotic cells, functioning as a large ribonucleoprotein complex composed of the 40S and 60S subunits (PubMed: 28439013). It translates genetic information from messenger RNA (mRNA) into functional proteins, a process essential for cellular growth, proliferation, and maintenance. In the context of disease, the 80S ribosome is often hijacked by viruses to produce viral proteins and is frequently upregulated in cancer cells to support rapid growth (PubMed: 26245381). Therapeutic targeting of the human ribosome is exemplified by Omacetaxine mepesuccinate, which binds to the ribosomal A-site to inhibit protein synthesis in leukemia cells (PubMed: 23133134). Furthermore, the ribosome is the target of potent toxins such as ricin, which enzymatically inactivates the 28S rRNA, leading to cell death (PubMed: 3065538). Understanding the structural nuances of the human 80S ribosome is vital for developing selective inhibitors that can distinguish between healthy and malignant or pathogen-infected cells.

Other names
Eukaryotic ribosomeCytoplasmic ribosome80S ribonucleoprotein complex
02

Mechanism of action

Inhibition of protein synthesis by preventing the correct positioning of aminoacyl-tRNA in the A-site of the 60S subunit or by site-specific depurination of the 28S rRNA, which prevents the binding of elongation factors (PubMed: 23133134, PubMed: 3065538).

03

Biological functions

Protein synthesisTranslation initiationTranslation elongationTranslation terminationPeptidyl transferase activity
04

Disease associations

CancerInfectionRibosomopathyDiamond-Blackfan anemiaTreacher Collins syndrome
05

Safety considerations

Systemic toxicity due to inhibition of essential protein synthesis in healthy cells (PubMed: 23133134)MyelosuppressionGastrointestinal distressPotential for off-target effects with high-dose antibiotics (PubMed: 21247015)
06

Interacting drugs

Omacetaxine mepesuccinate

7 more in the full profile.

07

Biomarkers

RPS19 mutation status (PubMed: 21430694)rRNA synthesis ratesNucleolar size and morphology

Beyond the preview

Go deeper on Human 80S ribosome (80S ribosome).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Human 80S ribosome (80S ribosome).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call